Search results
Neurogene (NASDAQ:NGNE) Now Covered by Analysts at Robert W. Baird
ETF DAILY NEWS· 4 days agoEquities research analysts at Robert W. Baird initiated coverage on shares of Neurogene (NASDAQ:NGNE – Get Free Report) in a note issued to investors on Tuesday, Briefing.com reports. The firm ...